| CVS HEALTH Corp (CVS) |
| Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | Q2-CY2014 | Q1-CY2014 | Q4-CY2013 |
| Balance Sheet Date | | 2025-Sep-30 | 2025-Jun-30 | 2025-Mar-31 | 2024-Dec-31 | 2024-Sep-30 | 2024-Jun-30 | 2024-Mar-31 | 2023-Dec-31 | 2023-Sep-30 | 2023-Jun-30 | 2023-Mar-31 | 2022-Dec-31 | 2022-Sep-30 | 2022-Jun-30 | 2022-Mar-31 | 2021-Dec-31 | 2021-Sep-30 | 2021-Jun-30 | 2021-Mar-31 | 2020-Dec-31 | 2020-Sep-30 | 2020-Jun-30 | 2020-Mar-31 | 2019-Dec-31 | 2019-Sep-30 | 2019-Jun-30 | 2019-Mar-31 | 2018-Dec-31 | 2018-Sep-30 | 2018-Jun-30 | 2018-Mar-31 | 2017-Dec-31 | 2017-Sep-30 | 2017-Jun-30 | 2017-Mar-31 | 2016-Dec-31 | 2016-Sep-30 | 2016-Jun-30 | 2016-Mar-31 | 2015-Dec-31 | 2015-Sep-30 | 2015-Jun-30 | 2015-Mar-31 | 2014-Dec-31 | 2014-Sep-30 | 2014-Jun-30 | 2014-Mar-31 | 2013-Dec-31 |
| Fiscal Period | | Q3-FY2025 | Q2-FY2025 | Q1-FY2025 | Q4-FY2024 | Q3-FY2024 | Q2-FY2024 | Q1-FY2024 | Q4-FY2023 | Q3-FY2023 | Q2-FY2023 | Q1-FY2023 | Q4-FY2022 | Q3-FY2022 | Q2-FY2022 | Q1-FY2022 | Q4-FY2021 | Q3-FY2021 | Q2-FY2021 | Q1-FY2021 | Q4-FY2020 | Q3-FY2020 | Q2-FY2020 | Q1-FY2020 | Q4-FY2019 | Q3-FY2019 | Q2-FY2019 | Q1-FY2019 | Q4-FY2018 | Q3-FY2018 | Q2-FY2018 | Q1-FY2018 | Q4-FY2017 | Q3-FY2017 | Q2-FY2017 | Q1-FY2017 | Q4-FY2016 | Q3-FY2016 | Q2-FY2016 | Q1-FY2016 | Q4-FY2015 | Q3-FY2015 | Q2-FY2015 | Q1-FY2015 | Q4-FY2014 | Q3-FY2014 | Q2-FY2014 | Q1-FY2014 | Q4-FY2013 |
| Price to Sales | .24x | .24x | .23x | .23x | .15x | .21x | .20x | .28x | .28x | .26x | .26x | .29x | .38x | .40x | .39x | .44x | .47x | .39x | .39x | .36x | .33x | .29x | .32x | .30x | .38x | .34x | .31x | .33x | .34x | .43x | .35x | .34x | .40x | .45x | | | | | | | | | | | | | | | |
| Price to Book | 1.32x | 1.31x | 1.13x | 1.11x | .75x | 1.05x | .99x | 1.36x | 1.33x | 1.21x | 1.22x | 1.34x | 1.71x | 1.77x | 1.62x | 1.80x | 1.81x | 1.51x | 1.50x | 1.39x | 1.29x | 1.11x | 1.25x | 1.19x | 1.51x | 1.31x | 1.16x | 1.20x | 1.15x | 2.19x | 1.84x | 1.68x | 1.95x | 2.37x | | | | | | | | | | | | | | | |
| Price to Earnings | 205.83x | 203.88x | 19.26x | 16.18x | 12.25x | 15.76x | 10.31x | 13.71x | 12.18x | 10.39x | 29.89x | 23.31x | 28.40x | 37.14x | 14.51x | 16.35x | 17.02x | 14.77x | 15.25x | 13.34x | 12.46x | 9.62x | 10.30x | 10.73x | 14.58x | 18.37x | 16.37x | - | - | 25.75x | 21.76x | 9.47x | 11.10x | 16.39x | | | | | | | | | | | | | | | |
| Price to Unlevered FCF | 15.34x | 15.19x | 18.26x | 14.38x | 8.93x | 46.86x | 14.06x | 12.33x | 9.77x | 7.94x | 5.01x | 5.49x | 9.10x | 6.43x | 7.66x | 8.21x | 8.65x | 7.37x | 9.46x | 7.63x | 6.66x | 6.05x | 6.24x | 6.61x | 9.30x | 8.03x | 8.38x | 11.30x | 9.78x | 18.67x | 11.24x | 12.93x | 12.07x | 10.04x | | | | | | | | | | | | | | | |
| Debt to Asset Ratio | | .71x | .70x | .70x | .70x | .70x | .70x | .70x | .69x | .70x | .71x | .70x | .69x | .69x | .67x | .68x | .68x | .68x | .68x | .69x | .70x | .70x | .71x | .72x | .71x | .71x | .72x | .73x | .70x | .72x | .73x | .43x | .60x | .62x | .63x | .63x | .61x | .62x | .63x | .61x | .60x | .60x | .50x | .50x | .49x | .48x | .47x | .48x | .47x |
| Current Ratio | | .83x | .80x | .82x | .81x | .80x | .86x | .81x | .86x | .86x | .86x | .92x | .95x | .94x | .91x | .88x | .88x | .94x | .95x | .93x | .91x | .95x | .98x | .99x | .94x | .92x | .95x | .99x | 1.03x | 2.44x | 2.34x | 2.37x | 1.02x | 1.05x | 1.09x | 1.08x | 1.18x | 1.16x | 1.11x | 1.20x | 1.26x | 1.43x | 1.30x | 1.30x | 1.37x | 1.39x | 1.45x | 1.51x | 1.64x |
✓